Letter: Histidine for treatment of uraemic anaemia

Phillips, M; Politis-Tsegos, C; de Wardener, H
March 1974
British Medical Journal;3/16/1974, Vol. 1 Issue 5906, p517
Academic Journal
No abstract available.


Related Articles

  • Decrease of thrombomodulin contributes to the procoagulant state of endothelium in haemolytic uraemic syndrome. Williams, Julie M.; Taylor, C. Mark // Pediatric Nephrology;Feb2005, Vol. 20 Issue 2, p243 

    Presents a letter to the editor focusing on the haemolytic uraemic syndrome.

  • HT-pre-eclampsiapostpartum haemolyticuraemic syndrome: good results can be achieved. Santos Nores, J.; Bravo López, J. J.; Borrajo Prol, M. P.; Iglesias Forneiro, A. // Nefrologia;Oct2010, Vol. 30 Issue 5, p593 

    A letter to the editor are presented in relation to the diagnosis of haemolytic-uraemic syndrome (HUS) that infected a pregnant woman and the use of plasmapheresis (PP) and prednisone as its treatment.

  • High circulating concentrations of glucagon in non-anaemic uraemic patients. McEvoy, Joseph; McCarroll, Anne Mary // British Medical Journal;7/1/1978, Vol. 2 Issue 6129, p17 

    Examines concentration of glucagon in non-anaemic uraemic patients. Causes of anaemia of renal failure patients; Possibility of maintaining normal haemoglobin concentration and packed cell volumes; Similarity of renal failure anaemia and glucagonoma. .

  • Cellular basis of uraemic cardiomyopathy: a role for erythropoietin? Smith, Katie; Semple, David; Bhandari, Sunil; Seymour, Anne-Marie L. // European Journal of Heart Failure;Aug2009, Vol. 11 Issue 8, p732 

    The use of erythropoietin (EPO) has revolutionized the treatment of anaemia associated with many conditions including chronic kidney disease (CKD). However, little is known of the cellular impact of EPO on the uraemic heart. The discovery that the EPO receptor (EPOR) is also expressed on...

  • Rescue therapy with eculizumab in a transplant recipient with atypical haemolytic-uraemic syndrome. Durán, Carlos E.; Blasco, Miquel; Maduell, Francisco; Campistol, Josep M. // Clinical Kidney Journal;Jan2012, Vol. 5 Issue 1, p28 

    Haemolytic–uraemic syndrome is a clinical syndrome characterized by thrombocytopaenia, non-autoimmune haemolytic anaemia and renal impairment. Pathological alterations in kidney samples show thrombotic microangiopathy. The underlying pathogenesis is endothelial cell injury with thrombotic...

  • Haemolytic uraemic syndrome: therapeutic effect of plasma infusions. Misiani, Rocco; Appiani, Aldo Claris; Edefonti, Alberto; Gotti, Eliana; Bettinelli, Alberto; Giani, Marisa; Rossi, Edoardo; Remuzzi, Giuseppe; Mecca, Giuliano // British Medical Journal (Clinical Research Edition);11/6/1982, Vol. 285 Issue 6351, p1304 

    Evaluates on the therapeutic effect of plasma infusion in children and adults. Characterization of haemolytic uraemic syndrome; Presence of thrombocytopenia and microangiopathic haemolytic anaemia in patients; Administration of antihypertensive drugs on patients.

  • Prostacyclin deficiency in hemoglobin-uremic syndrome. Webster, J.; Rees, A.J.; Lewis, P.J.; Hensby, C.N. // British Medical Journal;7/26/1980, Vol. 281 Issue 6235, p271 

    The haemolytic-uraemic syndrome is characterised by microangiopathic haemolytic anaemia, renal failure, and platelet consumption. Prostacyclin (PGI[SUB2]) deficiency may be the primary defect in haemolytic uraemic syndrome and the related condition, thrombotic thrombo-cytopenoic purpura.[1] We...

  • Successful treatment with sodium thiosulfate for calcific uraemic arteriolopathy.  // Nefrologia;2011, Vol. 31 Issue 3, p366 

    A letter to the editor is presented which discusses the observed efficacy of sodium thiosulfate in treating calcific uraemic arteriolopathy (CUA).

  • Haemolytic uraemic syndrome and pulmonary hypertension in a patient with methionine synthase deficiency. Labrune, P.; Zittoun, J.; Duvaltier, I.; Trioche, P.; Marquet, J.; Niaudet, P.; Odièvre, M.; Odièvre, M // European Journal of Pediatrics;1999, Vol. 158 Issue 9, p734 

    An 18-month-old girl presented with macrocytic megaloblastic anaemia followed by haemolytic uraemic syndrome. Metabolic investigations led to the identification of an inborn error of cobalamin metabolism consisting of defective methylcobalamin biosynthesis, probably cobalamin G, since methionine...

  • Remission of aHUS neurological damage with eculizumab. Ávila, Ana; Vizcaíno, Belén; Molina, Pablo; Gavela, Eva; Perez-Ebri, Maria; Pallardó, Luís // Clinical Kidney Journal;Apr2015, Vol. 8 Issue 2, p232 

    Atypical haemolytic uraemic syndrome (aHUS) is a rare disease characterized by haemolytic microangiopathic anaemia, thrombocytopaenia and acute onset of renal failure, in the absence of Escherichia coli infection. Renal damage usually progresses to end-stage renal disease (ESRD), sometimes being...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics